Hospital Clínic de Barcelona

What Hospital Clínic de Barcelona does

Hospital Clínic de Barcelona is a public tertiary and quaternary university hospital founded in 1906 and operated as a consortium between the Departament de Salut (through CatSalut) and the Universitat de Barcelona. The institution is organized around four strategic pillars: Assistència (healthcare delivery), Recerca (research via IDIBAPS), Docència (teaching), and Organització (organization). It serves the general patient population of Catalonia as a referral center for complex cases, including organ transplantation, oncology, neonatal intensive care, and home hospitalization, while also attracting international patients through a dedicated International Patient Service.

The hospital's technology and product portfolio includes the PortalCLÍNIC and El Meu Clínic digital patient portals, the SIMClínic clinical simulation center, Aulaclinic professional training platform, and Hospitalització a Domicili (hospital-at-home services). Research is conducted through the affiliated IDIBAPS foundation, which operates core scientific platforms across oncology, neurology, and hepatology. The institution has developed AI capabilities in diagnostic imaging and an explainable multimodal AI framework for skin lesion prediction with reported AUC values exceeding 0.95. It also serves as a clinical trial site for advanced therapies including Gyala Therapeutics' CAR-T cell therapy GYA01.

Hospital Clínic de Barcelona's revenue model is primarily based on public healthcare system funding through the CatSalut framework (recurrent population-based and service-based payments), supplemented by clinical research services conducted in partnership with biotech companies and medical education and training programs through IDIBAPS and SIMClínic. As a government-owned public institution, it does not have private shareholders or venture capital backing. Strategic priorities include the Clínic Campus infrastructure expansion designated as a project of general interest by the Government of Catalonia, international research collaborations, sustainability initiatives, and ecosystem development evidenced by spin-off generation such as Gyala Therapeutics.

Name

Hospital Clínic de Barcelona

Legal name

Hospital Clínic de Barcelona

Website

https://hospitalclinic.org

Company type

Private

Founded year

1906

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Hospital Clínic de Barcelona is a public tertiary university hospital serving Catalonia's general patient population through CatSalut-funded healthcare delivery, biomedical research via IDIBAPS, medical education, and clinical trials including CAR-T therapies.

Ownership category

akta.pro rank

Product category

Tertiary Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Hospitals (622)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Community & Regional General Hospitals (HLAFAAAB), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

Keywords

• Public hospital services
• Tertiary healthcare
• Clinical research
• Medical education
• University hospital

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Public Healthcare System Funding: Public healthcare funding through Catalonia's CatSalut system, which provides recurrent funding based on population coverage and healthcare service delivery under the national health system.
2. Clinical Research Services: Clinical trial operations conducted in partnership with biotech companies, providing research sites and patient populations for experimental therapies.
3. Medical Education and Training: Medical education and training programs for healthcare professionals, residents, and students through IDIBAPS and SIMClínic simulation center.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Hospital Clínic de Barcelona is a public university hospital in Barcelona, Spain, founded in 1906. It delivers tertiary healthcare services to patients, conducts biomedical research through its research institute IDIBAPS, and trains medical professionals as part of a consortium between the Departament de Salut and the Universitat de Barcelona. Its activity is organized around four pillars: healthcare, research, teaching, and organizational management, integrated into Spain's national public health system.

Product overview

Hospital Clínic de Barcelona operates as a major academic teaching hospital organized around four strategic pillars: healthcare assistance, research (through IDIBAPS), education, and organization. The institution offers a comprehensive portfolio of digital patient services including PortalCLÍNIC and El Meu Clínic portals for patient access to medical information. Research activities are conducted through IDIBAPS, which coordinates biomedical research across multiple therapeutic areas. Professional education is delivered via SIMClínic (clinical simulation), Aulaclinic (professional training), and Eixample Clínic (vocational training). Additional services include hospital-at-home care, an international patient services department, and a patient experience observatory. The hospital has also launched a sustainability initiative to reduce plastic use and promote recyclable materials.

Differentiator

Problem solved

Functional benefit

Brands

• IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): The research institute affiliated with Hospital Clínic de Barcelona, conducting biomedical research across multiple areas.

Products and services

• Tertiary Hospital Healthcare Services

Quantifiable outcome

• Treatment advances in intrahepatic cholangiocarcinoma have extended median survival from under one year to beyond two to three years for some patients with advanced disease, with approximately 45% of iCCA tumors harboring targetable genetic mutations.
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature2 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• HUB Alzheimer Barcelona NetworkcoreStrategic or Co-development Partner · 21 May 2026Hospital Clínic Barcelona is a member of the HUB Alzheimer Barcelona network, a collaborative research ecosystem of seven institutions in Barcelona working on Alzheimer's and dementia research. The network awarded its first collaborative predoctoral grants co-directed by researchers from at least two member institutions.
• Fundació Catalunya La PedreracoreStrategic or Co-development Partner · 21 May 2026Fundació Catalunya La Pedrera organizes the HUB Alzheimer Barcelona network and has maintained a 13-year commitment to people with Alzheimer's through its Memory Enhancement program and person-centered model of dignified aging.
• Government of CataloniacoreStrategic or Co-development Partner · 17 May 2026The Government of Catalonia designated the Clínic Campus as a project of general interest to eliminate bureaucratic obstacles and accelerate the development of the healthcare facility, signaling governmental commitment to prioritize this strategic health infrastructure project.
• Icahn School of Medicine at Mount SinaimajorStrategic or Co-development Partner · 17 April 2026Researchers from Icahn School of Medicine at Mount Sinai and Hospital Clínic de Barcelona co-published a comprehensive review in Cell journal applying the Hallmarks of Cancer framework to primary liver cancer, providing a roadmap linking disease biology to immunotherapy and precision medicine.
• Health Care Without HarmminorStrategic or Co-development Partner · 19 February 2026Health Care Without Harm is an organization working with hospitals to implement sustainable practices. Hospital Clínic Barcelona launched a comprehensive sustainability plan to rationalize plastic use and promote recyclable materials as part of global healthcare sustainability movement.
• Gyala TherapeuticscoreStrategic or Co-development Partner · 10 February 2026Gyala Therapeutics, a spin-off from Hospital Clínic Barcelona and Hospital La Fe, initiated a Phase I/IIa clinical trial of GYA01 CAR-T cell therapy at Hospital Clínic Barcelona. The trial targets relapsed or refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia, funded by €3.7 million from Spain's Ministry of Science.
• IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer)coreStrategic or Co-development PartnerIDIBAPS is the biomedical research institute associated with Hospital Clínic Barcelona and University of Barcelona. It is a foundation comprising these institutions along with Generalitat de Catalunya, conducting world-class biomedical research and driving innovation in healthcare.
• University of BarcelonacoreStrategic or Co-development PartnerUniversity of Barcelona is a founding partner of both Hospital Clínic de Barcelona (as part of the hospital consortium with CatSalut) and IDIBAPS research foundation, enabling integrated healthcare, research, and education.
• CatSalut (Servei Català de la Salut)coreStrategic or Co-development PartnerCatSalut is the Catalan Health Service, a founding member of the Hospital Clínic de Barcelona consortium. As the public health insurer, it provides the funding framework for healthcare service delivery at the hospital.
• Generalitat de CatalunyacoreStrategic or Co-development PartnerGeneralitat de Catalunya (Catalan Government) is a founding member of the IDIBAPS foundation and provides regulatory oversight and support for the hospital as part of the public healthcare system.
• Hospital La Fe (Valencia)majorStrategic or Co-development PartnerHospital La Fe in Valencia co-conducts the Phase I/IIa clinical trial of GYA01 CAR-T therapy alongside Hospital Clínic Barcelona, with both institutions receiving €3.7 million in funding from Spain's Ministry of Science.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hospital Universitari Vall d'Hebron: Largest public academic hospital in Barcelona and a direct Catalan competitor for tertiary referrals, clinical trials, and research talent, with comparable university affiliation and Catalan public-system funding model.
• Hospital de la Santa Creu i Sant Pau: Barcelona-based public university teaching hospital with overlapping catchment, similar consortium governance, and competing clinical-research and trial portfolio in the same metropolitan market.
• Hospital Universitario y Politécnico La Fe: Valencia-based public academic hospital that already co-runs the GYA01 CAR-T trial with Hospital Clínic; directly comparable in scale, Spanish public-system funding, and translational research orientation.
• Hospital General Universitario Gregorio Marañón: Madrid public university hospital with comparable complexity of services, teaching role, and clinical-trial activity, representing direct competition for national referral cases and research funding.
• Hospital Universitario 12 de Octubre: Major Madrid academic medical center with similar public-university consortium model, comparable bed-scale and tertiary/quaternary case mix, competing for national trial and referral share.
• Hospital Universitario Ramón y Cajal: Large Madrid public teaching hospital with analogous structure and academic affiliation, directly comparable for trial-sponsor selection and complex-case competition.

Regional players

• Hospital Universitari de Bellvitge: Catalan public university hospital serving a different sub-region of Catalonia; less research-intensive than Clínic but competes for regional referrals, talent, and CatSalut funding.

Broad incumbents

• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with integrated research and teaching; broadly comparable European AMC reference point for scale, complexity, and translational research output.
• Karolinska University Hospital: Swedish public academic medical center with university-affiliated research institute model similar to Hospital Clínic–IDIBAPS, serving as a benchmark for Nordic/European AMC operations.
• AP-HP (Assistance Publique – Hôpitaux de Paris): Largest public hospital system in Europe, anchored by university hospitals; relevant peer for understanding how a public AMC consortium operates at scale and competes for EU clinical research funding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/clinic_en
• LinkedInlinkedin.com/company/hospital-clinic-de-barcelona

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital Clínic de Barcelona